Vetmab Biosciences, Inc.

New Filing
CIK: 0001932050·Biotechnology·DELAWARE·Filed: Jun 10, 2022
Total Offering

$22

Amount Sold

$22

Investors

42

First Sale

May 15, 2022

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Denise Marie Bevers
Related Person
Richard Chin
Related Person
Hangjun Zhan
Related Person

Company

Vetmab Biosciences, Inc.

58 W. PORTAL AVE. #105

SAN FRANCISCO, CA, 94127

619-723-6476

SEC Filing

0001932050-22-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free